UTHR
United Therapeutics Corporation
NASDAQ · USHealthcareBiotechnology
$529.34-1.18%
Price as of Jul 20, 2026
UTHR profitability
United Therapeutics Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 86.6%
- EBITDA margin
- 54.1%
- EBIT margin
- 45.3%
- Net margin
- 40.6%
- Free cash flow margin
- 32.1%
Returns
- Return on equity
- 21.8%
- Return on assets
- 19.2%
- Return on invested capital
- 24.4%
- Asset turnover
- 0.43x
Cash efficiency
- Cash from operations
- $1.6B
- Cash per share
- $51
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.